Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 3,277 | 158 | 137 | 838 | 2,313 |
| Gross Profit | 3,277 | 158 | 137 | 838 | 2,313 |
| Operating Expenses | 27,262 | 33,362 | 25,001 | 15,699 | 13,063 |
| Operating Income | -23,985 | -33,204 | -24,864 | -14,861 | -10,750 |
| Interest Expense | -62 | 33 | 22 | 12 | 2 |
| Other Income | 34 | -273 | 59 | 9 | 20 |
| Pre-tax Income | -23,889 | -33,510 | -24,827 | -14,864 | -10,732 |
| Income Tax | N/A | N/A | N/A | N/A | -110 |
| Net Income Continuous | -23,889 | -33,510 | -24,827 | -14,864 | -10,622 |
| Net Income | $-23,889 | $-33,510 | $-24,827 | $-14,864 | $-10,622 |
| EPS Basic Total Ops | -0.56 | -0.81 | -0.60 | -0.38 | -0.17 |
| EPS Basic Continuous Ops | -0.56 | -0.81 | -0.60 | -0.38 | -0.18 |
| EPS Diluted Total Ops | -0.56 | -0.81 | -0.60 | -0.38 | -0.17 |
| EPS Diluted Continuous Ops | -0.56 | -0.81 | -0.60 | -0.38 | -0.18 |
| EBITDA(a) | $-23,868 | $-32,919 | $-24,789 | $-14,787 | $-10,540 |